Inhibition by insulin of resistin gene expression in 3T3-L1 adipocytes
An increased risk of NAION was noted in semaglutide users at 2 years (HR 2.39), 3 years (HR 2.44), and 4 years (HR 2.05) after treatment initiation
Robert Topp, RN, PhD Abstract This study examines the impact of implementing an automated point-of-sale diagnosis verification system for glucagon-like peptide-1 receptor agonists (GLP-1 RAs) compared to traditional utilization management approaches
[Abstract]2022 Apr 26;23(9):4783
Reported or theoretically plausible side effects of CJC 1295 and ipamorelin include: Water retention and peripheral oedema Flushing, headache, and dizziness, particularly after injection Tingling or numbness in the extremities Elevated IGF-1 levels, which over time may theoretically increase the risk of certain cancers, though a direct causal link has not been established in clinical studies [13] [14] Impaired glucose tolerance or insulin resistance GH excess and GH secretagogues are more commonly associated with raised blood glucose rather than hypoglycaemia